Atrys Health Sa Stock Fundamentals
| A2T Stock | EUR 2.93 0.07 2.33% |
ATRYS HEALTH SA fundamentals help investors to digest information that contributes to ATRYS HEALTH's financial success or failures. It also enables traders to predict the movement of ATRYS Stock. The fundamental analysis module provides a way to measure ATRYS HEALTH's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ATRYS HEALTH stock.
ATRYS |
ATRYS HEALTH SA Company Total Debt Analysis
ATRYS HEALTH's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current ATRYS HEALTH Total Debt | 71.4 M |
Most of ATRYS HEALTH's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ATRYS HEALTH SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Based on the latest financial disclosure, ATRYS HEALTH SA has a Total Debt of 71.4 M. This is 97.4% lower than that of the Healthcare sector and 78.02% lower than that of the Biotechnology industry. The total debt for all Germany stocks is 98.66% higher than that of the company.
ATRYS HEALTH SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ATRYS HEALTH's current stock value. Our valuation model uses many indicators to compare ATRYS HEALTH value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ATRYS HEALTH competition to find correlations between indicators driving ATRYS HEALTH's intrinsic value. More Info.ATRYS HEALTH SA is number one stock in ebitda category among its peers. It also is number one stock in net income category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ATRYS HEALTH's earnings, one of the primary drivers of an investment's value.ATRYS Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ATRYS HEALTH's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ATRYS HEALTH could also be used in its relative valuation, which is a method of valuing ATRYS HEALTH by comparing valuation metrics of similar companies.ATRYS HEALTH is currently under evaluation in total debt category among its peers.
ATRYS Fundamentals
| EBITDA | 6.68 M | |||
| Net Income | (2.02 M) | |||
| Cash And Equivalents | 17.6 M | |||
| Cash Per Share | 0.51 X | |||
| Total Debt | 71.4 M | |||
| Debt To Equity | 0.95 % | |||
| Current Ratio | 1.74 X | |||
| Book Value Per Share | 1.53 X | |||
| Cash Flow From Operations | (1.4 M) | |||
| Earnings Per Share | (0.05) X | |||
| Number Of Employees | 2.4 K | |||
| Beta | 0.15 | |||
| Market Capitalization | 330.53 M | |||
| Z Score | 2.4 |
About ATRYS HEALTH Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ATRYS HEALTH SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ATRYS HEALTH using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ATRYS HEALTH SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain. ATRYS HEALTH is traded on Frankfurt Stock Exchange in Germany.
Currently Active Assets on Macroaxis
Other Information on Investing in ATRYS Stock
ATRYS HEALTH financial ratios help investors to determine whether ATRYS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ATRYS with respect to the benefits of owning ATRYS HEALTH security.